1 min read

Deeptech Connect 2025

AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 – the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups. 🎯 A great opportunity to discover an investment opportunity in our novel cystic

AcesoTherapeutics will be attending Deeptech Connect on November 4, 2025 – the flagship event organized by the #SATT network, showcasing the best of French #Deeptech startups.

🎯 A great opportunity to discover an investment opportunity in our novel cystic fibrosis drug program, currently entering the preclinical (IND-enabling) stage.

πŸ”— for more information : πŸ“ Deeptech Connect – CENTQUATRE-PARIS βž• www.deeptechconnect.fr

Category

Published

November 2, 2025

Reading time

1 min read

Topic

Recognition

Publication

Press Release

Keep reading

Related news & insights

Aceso Advances Complementary Peptide Approaches to Enhance CFTR Function

Vienna, Austria – September 6–11, 2026 β€” Aceso Therapeutics is presenting new research at the 38th European Peptide Symposium, highlighting promising advances in peptide-based approaches to address key challenges in

A proud moment for the entire Aceso Therapeutics team

πŸ† A proud moment for the entire Aceso Therapeutics team: ACT-101 has been selected as a winner of the 2026 i-Lab Innovation Competition (28th edition), supported by Bpifrance under the

San Diego convention Center: June 22 – 25 – 2026

We are preparing to raise funds, with part already secured, to complete our regulatory preclinical studies, with CTA submission targeted for late 2027.

Get in touch

Partner with us to redefine cystic fibrosis care.

Whether you’re an investor, strategic partner, or member of the scientific community β€” we’d be glad to talk.

Email

Headquarters

Montpellier, France